Drug Profile
Research programme: influenza antibodies and vaccines - EPIC BIO
Alternative Names: Anti-influenza A H5 monoclonal antibodies - EPIC BIO; Broad-spectrum influenza H5 vaccine - EPIC BIO; Pandemic influenza antibodies and vaccines - EPIC BIOLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator EPIC BIO
- Class Monoclonal antibodies; Viral vaccines
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Influenza A virus infections
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Influenza-A-virus-infections in Singapore (Parenteral)
- 16 Jul 2016 No recent reports of development identified for research development in Influenza-A-virus-infections in USA (Parenteral)
- 12 Aug 2010 Early research in Influenza A virus infections in Singapore (Parenteral)